MahmoudianDehkordi, Siamak
Ahmed, Ahmed T.
Bhattacharyya, Sudeepa
Han, Xianlin
Baillie, Rebecca A. http://orcid.org/0000-0003-3966-6320
Arnold, Matthias http://orcid.org/0000-0002-4666-0923
Skime, Michelle K.
John-Williams, Lisa St.
Moseley, M. Arthur
Thompson, J. Will
Louie, Gregory http://orcid.org/0000-0002-3267-7070
Riva-Posse, Patricio
Craighead, W. Edward http://orcid.org/0000-0001-9957-0027
McDonald, William
Krishnan, Ranga
Rush, A. John http://orcid.org/0000-0003-2004-2382
Frye, Mark A.
Dunlop, Boadie W. http://orcid.org/0000-0002-4653-0483
Weinshilboum, Richard M. http://orcid.org/0000-0002-4911-7985
Kaddurah-Daouk, Rima http://orcid.org/0000-0003-1858-5732
Kaddurah-Daouk, Rima
Rush, John
Tenenbaum, Jessica
Moseley, Arthur
Thompson, Will
Louie, Gregory
Blach, Colette
Mahmoudiandehkhordi, Siamak
Baillie, Rebecca
Han, Xianlin
Bhattacharyya, Sudeepa
Frye, Mark
Weinshilboum, Richard
Ahmed, Ahmed
Neavin, Drew
Liu, Duan
Skime, Michelle
Rinaldo, Piero
Fiehn, Oliver
Brydges, Christopher
Mayberg, Helen
Choi, Ki Sueng
Cha, Jungho
Kastenmüller, Gabi
Arnold, Matthias
Binder, Elisabeth
Knauer-Arloth, Janine
Nevado-Holgado, Alejo
Shi, Liu
Dunlop, Boadie
Craighead, Ed
McDonald, William
Posse, Patricio Riva
Penninx, Brenda
Milaneschi, Yuri
Jansen, Rick
Krishnan, Ranga
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH108348)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG046171, U01AG061359, RF1AG051550)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Article History
Received: 4 February 2020
Revised: 1 October 2020
Accepted: 26 October 2020
First Online: 2 March 2021
Conflict of interest
: R.M.W. is a cofounder and stockholder in OneOme, LLC, a pharmacogenomic clinical decision-support company. A.J.R. has received consulting fees from Akili, Brain Resource Inc., Compass Inc., Curbstone Consultant LLC., Emmes Corp., Johnson and Johnson (Janssen), Liva-Nova, Mind Linc, Sunovion, and Taj Medical; speaking fees from Liva-Nova; and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX (for the Inventory of Depressive Symptoms and its derivatives). He has also named the coinventor on two patents: US Patent No. 7,795,033: Methods to Predict the Outcome of Treatment with Antidepressant Medication and US Patent No. 7,906,283: Methods to Identify Patients at Risk of Developing Adverse Events during Treatment with Antidepressant Medication. M.A.F. has received grant support from AssureRx Health Inc, Myriad, Pfizer Inc, NIMH (R01 MH079261), the National Institute on Alcohol Abuse and Alcoholism (P20AA017830) in the National Institutes of Health at the US Department of Health and Human Services, and the Mayo Foundation. He has been a consultant (for Mayo) to Janssen Global Services, LLC; Mitsubishi Tanabe Pharma Corp; Myriad Genetics, Inc; Sunovion Pharmaceuticals, Inc; and Teva Pharmaceutical Industries Ltd. He has received a continuing medical education, travel, and presentation support from the American Physician Institute and CME Outfitters. R.K.-D. is an inventor on key patents in the field of metabolomics. M.A. was supported by the National Institute on Aging [R01AG057452, RF1AG051550, and R01AG046171], National Institute of Mental Health [R01MH108348], and Qatar National Research Fund [NPRP8–061–3–011]. The funders listed above had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the paper; and decision to submit the paper for publication.